IELSG43High-dose chemotherapy and autologous stem cell transplant or consolidating conventional chemotherapy in primary CNS lymphoma – randomized phase III trial (MATRix)
Participants required:342 (enrolment completed)
Investigator responsible(s):G. Illerhaus, A. Ferreri
Objective(s):To compare the efficacy (in terms of progression-free survival) of two consolidation policies: high-dose chemotherapy followed by autologous stem-cell transplantation and chemotherapy at conventional doses (with a regimen specifically developed for CNS lymphoma).

Home | Go to Studies